Skip to main navigation Skip to search Skip to main content

Phase II study of romiplostim in patients with low- or Intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

  • Francis Joseph Giles

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Original languageEnglish (Ireland)
JournalBlood
Volume116
Publication statusPublished - 1 Jan 2010

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Kantarjian, H.M., Giles, F.J., Greenberg, P.L., Paquette, R.L., Wang, E.S., Gabrilove, J.L., Garcia-Manero, G., Hu, K., Franklin, J.L., Berger, D.P

Cite this